Knowledge Base - Massachusetts Biotechnology Council - Massachusetts Biotechnology Council

Pharma, Biotech & Medtech Half-Year Review 2019 EvaluatePharma USA, Inc. August 6, 2019

As 2018 drew to an end a notable lack of merger and acquisition activity among biopharma companies was probably one of the biggest grumbles heard about the sector. Read the full report. Read More

The Massachusetts Biotech Boom: Keeping Your Wealth Intact PEAK Financial Services Inc May 17, 2019 in White Papers,

https://massbiotechboom.com Read More

Hogan Lovells: Life Sciences and Health Care Horizons 2019 Hogan Lovells March 22, 2019

In the 2019 edition of our Life Sciences and Health Care Horizons publication, our global team identifies a number of current and evolving trends that are shaping the future of the industry. Read More

Vantage Pharma, Biotech and Medtech 2018 in Review EvaluatePharma USA, Inc. February 26, 2019

The Vantage 2018 in Review report paints a mixed picture for biopharma and medtech in 2018. Read More

Bridge's Biotech Market Report Bridge Real Estate February 14, 2019

The biotech “cluster” of East Cambridge has long been credited with supporting an industry collaboration and knowledge sharing environment not seen on this scale anywhere else, but where is the money Read More

Life Sciences and Health Care Horizons 2018 Hogan Lovells March 28, 2018 in White Papers,

Our global Life Sciences and Health Care team reports on current and evolving trends that are shaping the future of the industry. Read More

Navigating Challenges in Drug Discovery Charles River Laboratories January 26, 2018 in Presentation & Video Library,

Every complex discovery program can face a unique set of challenges. Read More

MA Responds with Additional Life Science Funding Update WithumSmith+Brown July 12, 2017 in White Papers,

As Massachusetts’s current 10-year, $1 billion life science program sunsets in 2018, Governor Baker plans to add an additional $500 million in life science program funding. Read More

Platforms versus products in the life sciences sector June 23, 2017

In an expert view piece, Dr Oded Ben-Joseph and Dr Shawn Manning, from investment bank Outcome Capital, advise on how life sciences companies can curtail risk by allocating time and money in a capital Read More

New York Unveils New Life Sciences Initiative WithumSmith+Brown February 3, 2017 in Advisories,

New York has announced some serious developments and may threaten Boston and San Francisco as the top spots in the biotech community. Read More